IONS: Ionis Pharma Projected Future Earnings

Public company logo of ionispharma.com (IONS)

The price trajectory for Ionis Pharmaceuticals (IONS) shown below highlights the dependence of profits on royalties from strategic allies, with the key metric standing at . The business's financial stability relies on significant cash reserves and complete independence from economic cycles. As a recognized leader in genetic medicine, Ionis Pharmaceuticals (IONS) possesses an impeccable reputation, establishing a foundation for the therapy of severe brain pathologies.

ionispharma.com (IONS): Company Profit Forecast from 07/04/2022 to 11/16/2026

Ionis Pharma (IONS) - metric breakdowns and financial figures

- price and consensus price forecast:
Fundamental company valuation:ionispharma.com, IONS
Core merchandise of Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals (IONS) maintains a leading position in the RNA therapeutics sector due to its transparent pipeline and the effective commercialization of licensing contracts. When analyzing the dynamics of future business profitability, an investor sees a mathematical projection of discounted cash flows that objectively captures the daily revision of market expectations, allowing for the timely recognition of overpayment risks and the assessment of the asset's fundamental value through the prism of future earnings.

Main competitors

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Expected Profit Repligen Corp. (RGEN)|Company Profit Forecast Avidity Biosciences|Expected Profit CRISPR Therapeutics Corp CRSP|WGS: Net Profit Forecast|ultragenyx.com - Projected Future Earnings|Beam Therapeutics - Future Net Profit|SRPT: Projected Future Earnings|TWST (Twist Bio) - Expected Profit|TXG (10xgenomics.com) - Projected Future Earnings|Projected Future Earnings Intellia Therapeutics, Inc.|Projected Future Earnings STOK|Company Profit Forecast BioLife Solutions Inc|Expected Profit Wave Pharma WVE|Projected Future Earnings Maze Therapeutics Corp MAZE|SION - Expected Profit|Prime Medicine, Inc. (PRME) - Future Profit|TSHA (Taysha Gene Therapies, Inc.) - Future Profit|QURE - Company Profit Forecast|MGTX (MeiraGTx Holdings plc) - Projected Future Earnings|Future Profit REGENXBIO Inc. (RGNX)|Expected Profit Solid Biosciences (SLDB)|ocugen.com (OCGN) - Projected Net Profit|Projected Future Earnings PACB (PacBio Corp)|Expected Net Income BNTC|DSGN: Future Profit|RCKT - Projected Future Earnings|Expected Net Income 4D Molecular Corp FDMT|Future Profit Lexeo|Expected Profit Korro Bio Inc.|Net Profit Forecast EDIT (Editas Medicine)|Expected Profit Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Expected Net Income|Projected Future Earnings CDXS (Codexis, Inc.)|Company Profit Forecast sangamo.com (SGMO)|nautilus.bio - Projected Future Earnings|Metagenomi (MGX) - Future Profit|DTIL: Projected Future Earnings|Expected Net Profit Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Projected Future Earnings|Future Profit Exicure (XCUR)|Expected Profit Celsion Corporation (IMNN)|PHIO - Expected Net Profit|Mustang Bio Inc - Future Profit|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings